Phase 2 study of trastuzumab deruxtecan as neoadjuvant treatment for HER2-positive gastric and gastroesophageal junction adenocarcinoma (EPOC2003).
- Resource Type
- Article
- Authors
- Takahari, Daisuke; Kawazoe, Akihito; Machida, Nozomu; Minashi, Keiko; Yamagata, Yukinori; Hara, Hiroki; Omori, Takeshi; Yamamoto, Manabu; Yasui, Hisateru; Nakayama, Izuma; Yamada, Takanobu; Kano, Masayuki; Yoshikawa, Takaki; Wakabayashi, Masashi; Komura, Yu; Sato, Akihiro; Kuwata, Takeshi; Kojima, Motohiro; Kinoshita, Takahiro; Shitara, Kohei
- Source
- Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p309-309, 185p
- Subject
- Language
- ISSN
- 0732183X